Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI

Clinical trial NCT06333314 · RECRUITING

Trial details

NCT number: NCT06333314
Sponsor: UNICANCER
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma Ampulla of Vater Carcinoma Adrenocortical Carcinoma Neuroendocrine Carcinoma Soft Tissue Sarcoma Small Bowel Adenocarcinoma Duodenum Adenocarcinoma Gastric Adenocarcinoma

Start date: 2024-07-23
Primary completion: 2028-10-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.